Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

Share Price is delayed by 15 minutes
Get Live Data
64.00    2.00 (3.23%)
Bid:
63.00
Ask:
65.00
Spread: 2.00 (3.175%)
Market Cap: £15.59m
MYX Live PriceLast checked at - London Stock Exchange

Intraday Mycelx Di Share Chart

Annual Meeting Statement

19 May 2015 07:00

RNS Number : 5727N
MyCelx Technologies Corporation
19 May 2015
 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

Annual Meeting Statement

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for commercial industrial markets worldwide, is holding its 2015 Annual Meeting at 11 a.m. (BST) today.

 

Tim Eggar, Chairman, will deliver the following statement to shareholders at the meeting.

 

"MYCELX is focused on its core commercial applications in regions where effective water treatment is critical to customers' ongoing operations. The Company continues to progress two major projects mentioned previously with trials now completed. The Directors anticipate that these projects will move into contract discussions. In addition, we have identified further turnaround projects in the Middle East that have approved budgets and new US onshore applications as targets for 2015 that will provide diversification to the advanced pipeline.

MYCELX is well positioned for turnaround projects which are short term, maintenance-driven and provide opportunity for quick media usage. These projects will support lease revenue streams as they are best addressed with modular, readily available equipment. MYCELX is ideally suited for these projects because of the flexible and effective way in which our media is deployed as well as the small footprint of our equipment and its ease of operation. Our successful completion of two turnaround projects this year highlights the continuing opportunities for the type of service required for reliable performance at our customers' operations.

 

However, we are operating in a sustained period of oil price volatility and this has resulted in slower deployment and less predictable expenditure of capital across the sector. As a result, predicting the timing of capital sales and revenue recognition continues to be difficult. Our current revenue projection is broadly in line with expectations but, as always, remains very dependent on the timing and successful completion of commercial negotiations.

 

Overall, MYCELX continues to see growing industry adoption of our technology. Wherever oil and gas production and petrochemical processing occurs, water is present and must be effectively treated. This is what MYCELX does best and where we will continue to move forward." 

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO Tel: +1 888 306 6843

Mark Clark, CFO

 

Numis Securities Limited Tel: +44 20 7260 1000

Corporate Finance

John Prior

Paul Gillam

 

Corporate Broking

James Black

Ben Stoop

 

Bell Pottinger Tel: +44 20 3772 2500

Nick Lambert

Henry Lerwill

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMPKFDQKBKBNPD
Date   Source Headline
3rd Jun 20267:00 amRNSAppointment of Non-Executive Director
12th May 20267:00 amRNSNew Gulf of Mexico Lease Award with Super Major
7th May 20267:00 amRNSFinal Results for the Year Ending 31 December 2025
16th Feb 202610:46 amRNSDirector Dealing
20th Jan 20267:00 amRNSTrading Update
22nd Dec 202511:27 amRNSHolding(s) in Company
7th Nov 20252:51 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTrading Update & $3.9m Project Award
1st Oct 20257:00 amRNSHolding(s) in Company
23rd Sep 20255:00 pmRNSResult of Annual Meeting
23rd Sep 20257:00 amRNSAppointment of New Chairman and Succession
17th Sep 20257:00 amRNSHalf Year Results Statement
11th Sep 20257:00 amRNSClosure of Restricted Stock Line
22nd Aug 20257:00 amRNSMailing of Notice of 2025 Annual Meeting
20th Aug 20257:00 amRNSOpening of $500,000 Line of Credit
17th Jul 20257:00 amRNSTrading Update
10th Jun 20257:00 amRNSMailing of 2024 Annual Report
21st May 20253:25 pmRNSDirector Dealing
19th May 202511:33 amRNSHolding(s) in Company
15th May 202511:21 amRNSHolding(s) in Company
12th May 20257:00 amRNSFinal Results for the Year Ending 31 December 2024
6th May 20257:00 amRNSPFAS Contract Award
1st May 20257:00 amRNS-REPA Announces Actions to Combat PFAS Contamination
10th Apr 20257:00 amRNSGrant of Share Options
7th Apr 20257:00 amRNSOperational and Trading Update
30th Jan 20257:00 amRNSChange of Adviser
6th Jan 20257:00 amRNSYear-end Update
29th Oct 20247:00 amRNSProject Award
24th Sep 20247:00 amRNSHalf Year Results Statement
23rd Sep 20247:00 amRNSTrading Update
6th Sep 202411:54 amRNSHolding(s) in Company
5th Sep 20245:17 pmRNSHolding(s) in Company
30th Aug 20247:00 amRNSBroker Option
23rd Aug 202411:05 amRNSDirector Dealings & Total Voting Rights
23rd Aug 20247:00 amRNSProposed Placing and Subscription
19th Jul 202410:36 amRNSPFAS Update
9th Jul 20242:23 pmRNSResult of AGM
9th Jul 20241:39 pmRNSHolding(s) in Company
4th Jun 20247:00 amRNS2023 Annual Report & Notice of 2024 Annual Meeting
21st May 20247:00 amRNSDirector Dealing
16th May 20247:00 amRNSFinal Results for the Year Ending 31 December 2023
24th Apr 20247:00 amRNSBusiness Update
11th Apr 20247:00 amRNSEPA Publishes National Drinking Water Standards
26th Mar 20243:30 pmRNSDirector Dealing
26th Mar 20247:00 amRNSDirector Dealing
22nd Mar 20247:00 amRNSDirector Dealing
21st Mar 20247:00 amRNSDirector Dealing
18th Mar 20247:00 amRNSGrant of Share Options to Chief Financial Officer
4th Mar 20247:00 amRNSSaudi Arabia Business Operation Sale Completion
22nd Feb 20247:02 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.